跳至主要内容
临床试验/NCT01639144
NCT01639144已完成不适用

Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing After Elective Foot and Ankle Surgery in Healthy Adults

Gary M. Kiebzak, Ph.D.2 个研究点 分布在 1 个国家目标入组 515 人开始时间: 2012年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
515
试验地点
2
主要终点
Postoperative Infection and Delayed Wound Healing.

研究概览

简要总结

The purpose of this study is to see if applying PRP and PPP to surgical sites and the closing incision helps prevent infection and slow wound healing.

详细描述

This will be a prospective, randomized study with patients blinded to either receiving platelet-rich plasma (PRP) and platelet-poor plasma (PPP) treatment or no treatment. We hypothesize that the antimicrobial properties of PRP and barrier properties of PPP (acting like a tissue sealant) will serve to inhibit deep incisional surgical site infection and help prevent delayed wound healing within 60 days of surgery. Thus, the incidence of infection and delayed wound healing will be lower in patients receiving PRP and PPP compared to patients who do not receive PRP and PPP. However, due to clinical equipoise, we do not know for certain that PRP and PPP is truly effective. The cost of preparing PRP and PPP is substantial, and involves a blood draw that would not otherwise be done. Thus, it is important to know if this treatment is effective or not.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elective foot and ankle surgery.

排除标准

  • Younger than 18 years, older than 80 years of age.

结局指标

主要结局

Postoperative Infection and Delayed Wound Healing.

时间窗: Infection: 30 days after surgery. Delayed wound healing: 60 days.

Postoperative deep incisional surgical site infection and delayed wound healing (lack of primary healing of skin edges typically with wound secretion).

次要结局

未报告次要终点

研究者

发起方
Gary M. Kiebzak, Ph.D.
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Gary M. Kiebzak, Ph.D.

Clinical Research Administrator

UHZ Sports Medicine Institute

研究点 (2)

Loading locations...

相似试验

Use of Platelet-Rich Plasma (PRP) and Platelet-Poor... | 临床试验